Research ArticleArticle
Open Access
Safety of Rituximab in Combination with Other Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: An Open-label Study
William F.C. Rigby, Philip J. Mease, Ewa Olech, Mark Ashby and Swati Tole
The Journal of Rheumatology April 2013, jrheum.120924; DOI: https://doi.org/10.3899/jrheum.120924
William F.C. Rigby
From the Department of Medicine, Dartmouth Medical School, Lebanon, New Hampshire; Swedish Medical Center, University of Washington, Seattle, Washington; University of Nevada School of Medicine, Las Vegas, Nevada; and Genentech Inc., South San Francisco, California, USA. Sponsored by Genentech Inc. and Biogen-Idec; and by F. Hoffmann-La Roche Ltd. W.F.C. Rigby, MD, Professor of Medicine, Dartmouth Medical School; P.J. Mease, MD, Director, Rheumatology Research, Swedish Medical Center and Clinical Professor, University of Washington School of Medicine; E. Olech, MD, Associate Professor of Medicine, University of Nevada School of Medicine; M. Ashby, PhD, Principal Statistical Scientist/Biostatistics; S. Tole, MD, MS, Medical Director, Genentech Inc. Address correspondence to Dr. W.F.C. Rigby, Dartmouth Medical School, 1 Medical Center Drive, HB 7510, Lebanon, NH 03756-0001, USA. Email: william.rigby@dartmouth.edu Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication January 25, 2013.
Philip J. Mease
From the Department of Medicine, Dartmouth Medical School, Lebanon, New Hampshire; Swedish Medical Center, University of Washington, Seattle, Washington; University of Nevada School of Medicine, Las Vegas, Nevada; and Genentech Inc., South San Francisco, California, USA. Sponsored by Genentech Inc. and Biogen-Idec; and by F. Hoffmann-La Roche Ltd. W.F.C. Rigby, MD, Professor of Medicine, Dartmouth Medical School; P.J. Mease, MD, Director, Rheumatology Research, Swedish Medical Center and Clinical Professor, University of Washington School of Medicine; E. Olech, MD, Associate Professor of Medicine, University of Nevada School of Medicine; M. Ashby, PhD, Principal Statistical Scientist/Biostatistics; S. Tole, MD, MS, Medical Director, Genentech Inc. Address correspondence to Dr. W.F.C. Rigby, Dartmouth Medical School, 1 Medical Center Drive, HB 7510, Lebanon, NH 03756-0001, USA. Email: william.rigby@dartmouth.edu Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication January 25, 2013.
Ewa Olech
From the Department of Medicine, Dartmouth Medical School, Lebanon, New Hampshire; Swedish Medical Center, University of Washington, Seattle, Washington; University of Nevada School of Medicine, Las Vegas, Nevada; and Genentech Inc., South San Francisco, California, USA. Sponsored by Genentech Inc. and Biogen-Idec; and by F. Hoffmann-La Roche Ltd. W.F.C. Rigby, MD, Professor of Medicine, Dartmouth Medical School; P.J. Mease, MD, Director, Rheumatology Research, Swedish Medical Center and Clinical Professor, University of Washington School of Medicine; E. Olech, MD, Associate Professor of Medicine, University of Nevada School of Medicine; M. Ashby, PhD, Principal Statistical Scientist/Biostatistics; S. Tole, MD, MS, Medical Director, Genentech Inc. Address correspondence to Dr. W.F.C. Rigby, Dartmouth Medical School, 1 Medical Center Drive, HB 7510, Lebanon, NH 03756-0001, USA. Email: william.rigby@dartmouth.edu Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication January 25, 2013.
Mark Ashby
From the Department of Medicine, Dartmouth Medical School, Lebanon, New Hampshire; Swedish Medical Center, University of Washington, Seattle, Washington; University of Nevada School of Medicine, Las Vegas, Nevada; and Genentech Inc., South San Francisco, California, USA. Sponsored by Genentech Inc. and Biogen-Idec; and by F. Hoffmann-La Roche Ltd. W.F.C. Rigby, MD, Professor of Medicine, Dartmouth Medical School; P.J. Mease, MD, Director, Rheumatology Research, Swedish Medical Center and Clinical Professor, University of Washington School of Medicine; E. Olech, MD, Associate Professor of Medicine, University of Nevada School of Medicine; M. Ashby, PhD, Principal Statistical Scientist/Biostatistics; S. Tole, MD, MS, Medical Director, Genentech Inc. Address correspondence to Dr. W.F.C. Rigby, Dartmouth Medical School, 1 Medical Center Drive, HB 7510, Lebanon, NH 03756-0001, USA. Email: william.rigby@dartmouth.edu Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication January 25, 2013.
Swati Tole
From the Department of Medicine, Dartmouth Medical School, Lebanon, New Hampshire; Swedish Medical Center, University of Washington, Seattle, Washington; University of Nevada School of Medicine, Las Vegas, Nevada; and Genentech Inc., South San Francisco, California, USA. Sponsored by Genentech Inc. and Biogen-Idec; and by F. Hoffmann-La Roche Ltd. W.F.C. Rigby, MD, Professor of Medicine, Dartmouth Medical School; P.J. Mease, MD, Director, Rheumatology Research, Swedish Medical Center and Clinical Professor, University of Washington School of Medicine; E. Olech, MD, Associate Professor of Medicine, University of Nevada School of Medicine; M. Ashby, PhD, Principal Statistical Scientist/Biostatistics; S. Tole, MD, MS, Medical Director, Genentech Inc. Address correspondence to Dr. W.F.C. Rigby, Dartmouth Medical School, 1 Medical Center Drive, HB 7510, Lebanon, NH 03756-0001, USA. Email: william.rigby@dartmouth.edu Full Release Article. For details see Reprints/Permissions at jrheum.org. Accepted for publication January 25, 2013.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Safety of Rituximab in Combination with Other Biologic Disease-modifying Antirheumatic Drugs in Rheumatoid Arthritis: An Open-label Study
William F.C. Rigby, Philip J. Mease, Ewa Olech, Mark Ashby, Swati Tole
The Journal of Rheumatology Apr 2013, jrheum.120924; DOI: 10.3899/jrheum.120924